Internal Server Error

Coherence - About the company

Coherence is a series A company based in San Francisco (United States), founded in 2022 by Ben Woodington and Elise Jenkins. It operates as a Developer of therapeutic neurotechnology managing cancer from inside the body. Coherence has raised $57.3M in funding from investors like Founders Fund, Blackbird Ventures and Artesian. The company has 78 active competitors, including 21 funded and 12 that have exited. Its top competitors include companies like Alpha Tau Medical, RefleXion and Mevion Medical Systems.

Company Details

Developer of therapeutic neurotechnology managing cancer from inside the body. The company designs implantable electronics for sensing and stimulating the nervous system. It focuses on intervening in how cancer communicates within the body. The company utilizes artificial intelligence and machine learning to decode electrical signals.
Social
X
Key Metrics
Founded Year
2022
Location
San Francisco, United States
Stage
Series A
Total Funding
$57.3M in 3 rounds
Latest Funding Round
Ranked
Employee Count
33 as on Sep 30, 2026
Similar Companies
Sign up to download Coherence's company profile

Coherence's funding and investors

Coherence has raised a total funding of $57.3M over 3 rounds. Its first funding round was on Apr 28, 2023. Its latest funding round was a Series A round on Oct 22, 2026 for $*****. 14 investors participated in its latest round. Coherence has 17 institutional investors and 7 angel investors.

Here is the list of recent funding rounds of Coherence:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Oct 22, 2026
9365994
Series A
3369982
6843938
6988677
7923080
Nov 04, 2025
6546382
Seed
9186778
7213640
1260524
Apr 28, 2023
5889020
Seed
8997361
5133088
lockAccess funding benchmarks and valuations. Sign up today!

Coherence's founders and board of directors

Founder? Claim Profile
The founders of Coherence are Ben Woodington and Elise Jenkins. Ben Woodington is the CEO of Coherence.
Here are the details of Coherence's key team members:

Coherence's employee count trend

Coherence has 33 employees as of Sep 26. Here is Coherence's employee count trend over the years:
Employee count trend for Coherence
lockUncover Coherence's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Coherence's Competitors and alternates

Top competitors of Coherence include Alpha Tau Medical, RefleXion and Mevion Medical Systems. Here is the list of Top 10 competitors of Coherence, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Alpha Tau Medical
Alpha Tau Medical
2015, Tel Aviv (Israel), Public
Developer of radiotherapy technique for the treatment of solid cancer tumors
$55M
68/100
2nd
Logo for RefleXion
RefleXion
2009, Hayward (United States), Series F
Provider of biology-guided radiotherapy system
$542M
66/100
3rd
Logo for Mevion Medical Systems
Mevion Medical Systems
2004, Littleton (United States), Series F
Proton therapy systems for oncology
$500M
62/100
4th
Logo for ABK Biomedical
ABK Biomedical
2012, Halifax (Canada), Series D
Developer of imageable embolic medical devices targeting benign and malignant hypervascular tumors
$140M
61/100
5th
Logo for Vergent Biosciences
Vergent Biosciences
2014, Minneapolis (United States), Series B
Developing tumor-targeted imaging agents for improved cancer surgery outcomes
$57M
61/100
6th
Logo for Elekta
Elekta
1972, Gurugram (India), Public
Manufacturer of radiation therapy systems and cancer treatment technology equipment
-
61/100
7th
Logo for ZAP-X
ZAP-X
2014, San Carlos (United States), Series E
Developer of gyroscopic radiosurgery platform
$196M
60/100
8th
Logo for Alpheus Medical
Alpheus Medical
2014, Chanhassen (United States), Series B
Developer of Sonodynamic therapy device for brain cancer
$76.5M
58/100
9th
Logo for Cel-Sci
Cel-Sci
1983, Vienna (United States), Public
Developer of immunotherapy products for the treatment of cancer and infectious diseases
-
53/100
10th
Logo for AiRato
AiRato
2022, Sendai (Japan), Seed
AI-powered radiation therapy platform for cancer treatment
$4.88M
49/100
14th
Logo for Coherence
Coherence
2022, San Francisco (United States), Series A
Developer of therapeutic neurotechnology managing cancer from inside the body
$57.3M
46/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Coherence's competitors? Click here to see the top ones

Coherence's Investments and acquisitions

Coherence has made no investments or acquisitions yet.

Reports related to Coherence

Here is the latest report on Coherence's sector:

News related to Coherence

Media has covered Coherence for 1 event in last 1 year.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Coherence

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford